UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Annals of oncology, 2014-09, Vol.25 (9), p.1813-1820

2014

Volltextzugriff (PDF)

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Supportive care in cancer, 2018-03, Vol.26 (3), p.869-878

2018

Volltextzugriff (PDF)

Structural evidence for the roles of divalent cations in actin polymerization and activation of ATP hydrolysis

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (41), p.10345-10350

2018

Volltextzugriff (PDF)

Systems biology approach for enhancing limonene yield by re-engineering Escherichia coli

NPJ systems biology and applications, 2024-10, Vol.10 (1), p.109-14, Article 109

2024

Volltextzugriff (PDF)

Caractéristiques pronostiques des tumeurs neuroendocrines (TNE) pancréatiques non syndromique : analyse de la base de données RENATEN Limousin

Annales d'endocrinologie, 2016-09, Vol.77 (4), p.320-320

2016

Volltextzugriff (PDF)

Role of GRB2‐associated binder 1 in epidermal growth factor receptor‐induced signaling in head and neck squamous cell carcinoma

International journal of cancer, 2013-03, Vol.132 (5), p.1042-1050

2013

Volltextzugriff (PDF)

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Annals of oncology, 2020-07, Vol.31 (7), p.942-950

2020

Volltextzugriff (PDF)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Annals of oncology, 2017-10, Vol.28 (10), p.2526-2532

2017

Volltextzugriff (PDF)

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2018-04, Vol.29 (4), p.985-991

2018

Volltextzugriff (PDF)

Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

European radiology, 2016-03, Vol.26 (3), p.900-909

2016

Volltextzugriff (PDF)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Annals of oncology, 2014-03, Vol.25 (3), p.682-688

2014

Volltextzugriff (PDF)

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

Annals of oncology, 2016-08, Vol.27 (8), p.1585-1593

2016

Volltextzugriff (PDF)

Advances in Structural Biology and the Application to Biological Filament Systems

BioEssays, 2018-04, Vol.40 (4), p.e1700213-n/a

2018

Volltextzugriff (PDF)

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

Annals of oncology, 2017-09, Vol.28 (9), p.2219-2224

2017

Volltextzugriff (PDF)

Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer

B-ENT (Leuven), 2011, Vol.7 (1), p.1-6

2011

Volltextzugriff (PDF)

Defining pseudoprogression in glioblastoma multiforme

European journal of neurology, 2013-10, Vol.20 (10), p.1335-1341

2013

Volltextzugriff (PDF)

P17.22 LOMUSTIN OR BEVACIZUMAB AT FIRST RECURRENCE OF GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii92-ii92

2014

Volltextzugriff (PDF)

Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes

Current otorhinolaryngology reports, 2017, Vol.5 (1), p.83-91

2017

Volltextzugriff (PDF)

P16.07 BEVACIZUMAB AS PALLIATIVE TREATMENT OF FAMILIAL SCHWANNOMATOSIS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii79-ii79

2014

Volltextzugriff (PDF)

PAIN MANAGEMENT IN PALLIATIVE CANCER PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF HIGH DOSAGES OF TRANSDERMAL BUPRENORPHINE

Acta clinica belgica (English ed. Online), 2013-03, Vol.68 (2), p.87-91

2013

Volltextzugriff (PDF)

Prospective observational study on the use of buprenorphine in patients with palliative cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e19564-e19564

2011

Volltextzugriff (PDF)

A CASE SERIES OF EMBRYONAL RHABDOMYOSARCOMA OF THE HEAD AND NECK IN ADULTS

Acta clinica belgica (English ed. Online), 2010-11, Vol.65 (6), p.404-410

2010

Volltextzugriff (PDF)

JS07.4.A A PHASE 0/IA STUDY OF BRIGIMADLIN CONCENTRATION IN BRAIN TISSUE AND A DOSE ESCALATION STUDY OF BRIGIMADLIN PLUS RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2024-10, Vol.26 (Supplement_5), p.v13-v13

2024

Volltextzugriff (PDF)

P05.01.B PROGNOSTIC MARKERS OF DNA METHYLATION AND NGS SEQUENCING IN PROGRESSIVE GLIOBLASTOMA FROM THE EORTC-26101 TRIAL

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii43-ii43

2023

Volltextzugriff (PDF)

OS05.2.A MGMT promoter status in IDH1/2 mutant anaplastic astrocytoma patients assessed by DNA methylation profiling and qMS-PCR: a report from the EORTC Brain Tumor Group

Neuro-oncology (Charlottesville, Va.), 2021-09, Vol.23 (Supplement_2), p.ii6-ii7

2021

Volltextzugriff (PDF)

1 – 25 von 6.072

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.982)
Mit Volltextzugriff
(4.872)

Publikationsform

Artikel
(5.512)
Tagungsberichte
(287)
Buchkapitel
(191)
Bücher
(36)
Berichte
(18)
magazinearticle
(13)
Reviews
(11)
Texte
(2)
Webseiten
(2)

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.288)
Life Sciences & Biomedicine
(2.095)
Humans
(1.728)
Male
(1.093)
Female
(1.065)
Biological And Medical Sciences
(814)
Physical Sciences
(811)
Physics
(691)
Middle Aged
(666)
Adult
(647)
Medical Sciences
(629)
Aged
(538)
Technology
(477)
Animals
(464)
Life Sciences
(415)
Surgery
(302)
Adolescent
(261)
Fundamental And Applied Biological Sciences. Psychology
(245)
Exact Sciences And Technology
(214)
Cardiovascular System & Cardiology
(209)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Structural evidence for the roles of divalent cations in actin polymerization and activation of ATP hydrolysis

Systems biology approach for enhancing limonene yield by re-engineering Escherichia coli

Caractéristiques pronostiques des tumeurs neuroendocrines (TNE) pancréatiques non syndromique : analyse de la base de données RENATEN Limousin

Role of GRB2‐associated binder 1 in epidermal growth factor receptor‐induced signaling in head and neck squamous cell carcinoma

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

Advances in Structural Biology and the Application to Biological Filament Systems

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer

Defining pseudoprogression in glioblastoma multiforme

P17.22 LOMUSTIN OR BEVACIZUMAB AT FIRST RECURRENCE OF GLIOBLASTOMA

Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes

P16.07 BEVACIZUMAB AS PALLIATIVE TREATMENT OF FAMILIAL SCHWANNOMATOSIS

PAIN MANAGEMENT IN PALLIATIVE CANCER PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF HIGH DOSAGES OF TRANSDERMAL BUPRENORPHINE

Prospective observational study on the use of buprenorphine in patients with palliative cancer

A CASE SERIES OF EMBRYONAL RHABDOMYOSARCOMA OF THE HEAD AND NECK IN ADULTS

JS07.4.A A PHASE 0/IA STUDY OF BRIGIMADLIN CONCENTRATION IN BRAIN TISSUE AND A DOSE ESCALATION STUDY OF BRIGIMADLIN PLUS RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

P05.01.B PROGNOSTIC MARKERS OF DNA METHYLATION AND NGS SEQUENCING IN PROGRESSIVE GLIOBLASTOMA FROM THE EORTC-26101 TRIAL

OS05.2.A MGMT promoter status in IDH1/2 mutant anaplastic astrocytoma patients assessed by DNA methylation profiling and qMS-PCR: a report from the EORTC Brain Tumor Group

Suchergebnisse filtern